| REQUIRED BUILD |
-
- PSO*7.0*73
- ACTION: Don't install, leave global
-
- PSO*7.0*148
- ACTION: Don't install, leave global
-
- PSO*7.0*122
- ACTION: Don't install, leave global
-
- PSO*7.0*126
- ACTION: Don't install, leave global
-
- PSO*7.0*177
- ACTION: Don't install, leave global
-
- PSO*7.0*184
- ACTION: Don't install, leave global
-
- PSO*7.0*227
- ACTION: Don't install, leave global
-
- YS*5.01*90
- ACTION: Don't install, leave global
-
- PSO*7.0*237
- ACTION: Don't install, leave global
|
| DESCRIPTION OF ENHANCEMENTS |
The Department of Veterans Affairs National Clozapine Coordinating Center
read the patch description of YS*5.01*90 for complete details of this new
enhancement.
This Outpatient Pharmacy patch PSO*7*222 contains the following
must-do-work enhancements for Clozapine dispensing:
1. Adjust the business rules to disallow prescription processing without
override if 3500/mm3>WBC>3000/mm3 and 2000/mm3>ANC>1500/mm3.
These levels require twice weekly blood testing until the WBC
stabilizes above 3500/mm3 and ANC above 2000/mm3 with no signs of
(NCCC), is requesting modifications to Veterans Health Information Systems
infection.
2. Modify routine logic to recognize the new monthly status and apply the
appropriate restrictions for lab draw checks.
3. Add a new field to the PRESCRIPTION file (#52) to store ANC value and
modify routine logic to require both a WBC and ANC be drawn and
reported before drug dispensing is allowed.
4. Modify routine logic to prevent local users from editing the Patient
Status within Clozapine module.
This patch transports the following fields:
and Technology Architecture (VistA) Outpatient Pharmacy and Mental Health
1. The field length of the WBC RESULT field (#302) of the PRESCRIPTION
file (#52) is modified from 3 to 5 digits to accommodate values up to
99999 as these values will be stored in 1000s.
2. A new field ANC RESULTS field (#304) is added to the PRESCRIPTION file
(#52) to store the ANC test value.
3. The field name of REASON FOR LOCKOUT field (#4) of the CLOZAPINE
PRESCRIPTION OVERRIDES file (#52.52) is changed to REASON FOR OVERRIDE.
The set of codes have been modified and three new codes were added. The
modified Data Dictionary (DD) is as follows:
applications to meet revisions in the Food and Drug Administration (FDA)
52.52,4 REASON FOR OVERRIDE 0;5 SET (Required)
'1' FOR NO WBC IN LAST 7 DAYS;
'2' FOR NO VERIFIED WBC;
'3' FOR LAST WBC RESULT < 3500;
'4' FOR 3 SEQ. WBC DECREASE;
'5' FOR LAST ANC RESULT < 2000;
'6' FOR 3 SEQ. ANC DECREASE ;
'7' FOR NCCC AUTHORIZED;
monitoring requirements for blood monitoring in patients being treated
The Outpatient Pharmacy patch PSO*7*227, TRANSITIONAL PHARMACY BENEFIT
(TPB) inactivation, was placing the TPB HL7 Data Extract/Transmission [PSO
TPB HL7 EXTRACT] option out of order. Sites testing patch PSO*7*227
recommended that we remove this task totally from the OPTION SCHEDULING
file (#19.2). Therefore, a post-install routine (PSOP222) is included in
this patch PSO*7*222 to delete the TPB HL7 Data Extract/Transmission [PSO
TPB HL7 EXTRACT] option from the OPTION SCHEDULING file (#19.2).
The post-install routine will also provide the following changes:
1. As the patch PSO*7*227 inactivated the TPB functionality, the security
access codes for the TPB ELIGIBILITY file (#52.91) still remains open.
with Clozapine.
These codes will be changed to "@" sign restricting access to
programmers only.
2. The read access code of the PRESCRIPTION REFILL REQUEST file (#52.43)
is currently set to "@" sign (programmer access). As per the
Electronic, Error and Enhancement Report (E3R) 19725 request, this will
be changed to "Pp" (Pharmacy Package) access.
This patch PSO*7*222 is associated with the MENTAL HEALTH V. 5.01 patch
YS*5.01*90 and patch YS*5.01*90 is a required patch for PSO*7*222. Please
|
